Harri Sihto,Olli-Pekka Pulkka,Olli Kallioniemi,Heikki Joensuu
申请号:
US15028947
公开号:
US20160354376A1
申请日:
2014.10.17
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a solid tumor, such as gastrointestinal stromal tumor (GIST) or a liposarcoma, which express phosphodiesterase 3 enzymes, in a human patient.